Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

King Tigan Suppository sNDA Pushed To 2004 Under Revised FDA Agreement

Jan 06 2003

• By The Pink Sheet

Related Content

Bertek And Amide Sue FDA To Remove Unapproved Digoxins

Oct 16 2000

Synthroid Sales Expected To Grow 12% For Year Following NDA Approval

Jul 29 2002

King Tigan 300 Mg Promos Planned After FDA Trimethobenzamide Notice

Feb 25 2002

FDA Seeks To Cut Abbott Synthroid Distribution To 60% By August 2002

Jul 16 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window